US EditionPublished • loading... • Updated
ICPO and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological ...
Summary by Hastings Tribune
2 Articles
2 Articles
ICPO and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological cancer in Latin America
The partnership strengthens education, innovation, and patient access by combining global expertise with regional leadership in precision oncology. February 27, 2026 – Wiesbaden, Germany and Miami, USA. The International Centers for Precision Oncology (ICPO) Foundation and the UroTeragLATAM Foundation have signed a Memorandum of Understanding during the WFNMB congress in Cartagena, Colombia to collaborate on […] The post ICPO and UroTeragLATAM s…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
